At least 10 US PE-backed healthcare provider platforms will list publicly next year, breaking 2021’s record of 6, according to Pitchbook’s new report. If there’s a cooling in the public markets, sponsor-to-sponsor buyouts could fill the gap, according to the report, due to the ease of the transaction process for healthcare providers. Strategic partner sales, including payers and hospitals, may also see a rise in activity. Read more. |
Related Posts
Eagles Landing Health in GA to Rebrand as Aylo
Beyond the traditional family medicine model, patients have access to services like diagnostic imaging, diabetic care (endocrinology), pediatrics and sleep medicine.
August 17, 2022
J.P. Morgan is Betting Big on the Future of Healthcare
Morgan Health is aggressively investing in “promising healthcare companies” that are meaningfully creating positive disruption in multiple spaces, ranging from home healthcare, virtual care delivery, to healthcare analytics.
November 28, 2022
Value-Based Care Collides with Competition: Deal Impacts for Private Equity Companies
On the Value-based Care Collides with Competition series, Ropes & Gray attorneys explore how aggressive federal and state enforcement of antitrust and other competition laws appears to be in tension with the nationwide shift to value-based care models.
June 20, 2023
Dry Powder Plentiful for Behavioral Health Acquisitions, but Expect Caution and Strategic Deals in 2023
As the Federal Reserve continues to raise interest rates, many behavioral health stakeholders are tightening their belt on merger and acquisition deals. But for providers with cash, it could be a prime time to strike.
October 20, 2022